Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma. - Hecht, J.R.; Oberoi, A.; Garralda Cabanas, E.; Jae Chon, H.; Digklia, A.; Rottey, S.; Martin Jimenez, M.; Chaney, M.; Hippenmeyer, J.; Lawrence, T.; Liu, K.; Hamidi, A.; et al. (2025)